Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in human esophageal squamous cell carcinoma and its correlation with angiogenesis

World Chinese Journal of Digestology

Volumn 17, Issue 22, 2009, Pages 2259-2265

  Chan, Song Miao ^a   Ou, Xi Long ^b   Sun, Wei Hao ^c   Chen, Guo Sheng ^b   Yan, Fang ^b  

^a Shanghai Meishan Hospital   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Cyclooxygenase 2; Esophageal squamous cell carcinoma; Immunnohistochemistry; Matrix metalloproteinase 9

Indexed keywords

CD34 ANTIBODY; CYCLOOXYGENASE 2; GELATINASE B;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION;

EID: 70349641789     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v17.i22.2259     Document Type: Article

References (28)

1. van Rees BP, Saukkonen K, Ristimäki A, Polkowski W, Tytgat GN, Drillenburg P, Offerhaus GJ. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196: 171-179 (Pubitemid 34110898)
2. Yoon SO, Park SJ, Yun CH, Chung AS. Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. J Biochem Mol Biol 2003; 36: 128-137 (Pubitemid 36836264)
3. Cui XN, Hou L, Liu JW, Ling MY. [Matrix metal loproteinases map of lymphogenous metastasis of hepatocarcinoma cell in mice] Ai Zheng 2002; 21: 1192-1196
4. Weidner N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 1998; 184: 119-122
5. Folkman J. Angiogenesis research: from laboratory to clinic. Forum (Genova) 1999; 9: 59-62
6. Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804 (Pubitemid 27475940)
7. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 1995; 36: 169-180
8. Deasy BM, O'Sullivan-Coyne G, O'Donovan TR, McKenna SL, O'Sullivan GC. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)- independent mechanisms. Cancer Lett 2007; 256: 246-258 (Pubitemid 47432720)
9. Sun WH, Sun YL, Fang RN, Shao Y, Xu HC, Xue QP, Ding GX, Cheng YL. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 2005; 35: 707-713 (Pubitemid 43091655)
10. Dicken BJ, Graham K, Hamilton SM, Andrews S, Lai R, Listgarten J, Jhangri GS, Saunders LD, Damaraju S, Cass C. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 2006; 243: 64-73 (Pubitemid 43054056)
11. Masferrer JL, Leahy KM, Koki AT, Zweifel BS, Settle SL, Woerner BM, Edwards DA, Flickinger AG, Moore RJ, Seibert K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 2000; 60: 1306-1311 (Pubitemid 30151999)
12. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporaso NE, Liotta LA, Harris CC. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 2000; 6: 4739-4744 (Pubitemid 32110413)
13. Zimmermann KC, Sarbia M, Weber AA, Borchard F, Gabbert HE, Schrör K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999; 59: 198-204 (Pubitemid 29062978)
14. Ratnasinghe D, Tangrea J, Roth MJ, Dawsey S, Hu N, Anve r M, Wang QH, Taylor PR. Expres s ion of cyc looxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anticancer Res 1999; 19: 171-174
15. Hashimoto N, Inayama M, Fujishima M, Shiozaki H. Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma. Hepatogastroenterology 2007; 54: 758-760 (Pubitemid 46903717)
16. Kuo KT, Chow KC, Wu YC, Lin CS, Wang HW, Li WY, Wang LS. Clinicopathologic significance of cyclooxygenase-2 overexpression in esophageal squamous cell carcinoma. Ann Thorac Surg 2003; 76: 909-914 (Pubitemid 37100771)
17. Kawabe A, Shimada Y, Uchida S, Maeda M, Sato F, Itami A, Imamura M. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 2002; 62: 46-54 (Pubitemid 34124225)
18. Matsuyama Y, Takao S, Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J Surg Oncol 2002; 80: 105-110 (Pubitemid 34569178)
19. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-744 (Pubitemid 30768157)
20. Yao M, Kargman S, Lam EC, Kelly CR, Zheng Y, Luk P, Kwong E, Evans JF, Wolfe MM. Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth and metastatic potential of colorectal carcinoma in mice. Cancer Res 2003; 63: 586-592 (Pubitemid 36158135)
21. Suzuki T, Kuwabara Y, Iwata H, Mitani M, Shinoda N, Sato A, Mitsui A, Sugiura M, Kato J, Fujii Y. Role of matrix metalloproteinase-9 in in vitro invasion of esophageal carcinoma cells. J Surg Oncol 2002; 81: 80-86
22. Huang WZ, Fu JH, Wang DK, Hu Y, Liu MZ, Yang H, Feng YF, Zheng B, Wang G, Luo KJ, Wen J, Rong TH. Overexpression of cyclooxygenase-2 is associated with chemoradiotherapy resistance and prognosis in esophageal squamous cell carcinoma patients. Dis Esophagus 2008; 21: 679-684
23. Takatori H, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Sasaki K, Tamotsu K, Owaki T, Ishigami S, Aikou T. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma. Eur J Surg Oncol 2008; 34: 397-402
24. Liu JF, Jamieson G, Wu TC, Zhang SW, Wang QZ, Drew P. Cyclooxygenase-2 expression in squamous cell carcinoma of the esophagus. Dis Esophagus 2006; 19: 350-354 (Pubitemid 44390440)
25. Liu JF, Zhu GJ, Jamieson GG, Wu TC, Zhu TN, Shan BE, Drew PA. NS-398 induces apoptosis in human esophageal cancer cells through inhibition of NF-kappaB downstream regulation of cyclooxygenase-2. Cancer Invest 2009; 27: 17-23
26. Pak KC, Lam KY, Law S, Tang JC. The inhibitory effect of Gleditsia sinensis on cyclooxygenase-2 expression in human esophageal squamous cell carcinoma. Int J Mol Med 2009; 23: 121-129
27. Liu X, Li P, Zhang ST, You H, Jia JD, Yu ZL. COX-2 mRNA expression in esophageal squamous cell carcinoma (ESCC) and effect by NSAID. Dis Esophagus 2008; 21: 9-14